Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

February 1, 2016; Volume 57,Issue Supplement 1

Clinical and Translational Molecular Imaging of Breast Cancer

  • You have access
    Introduction and Overview
    Johannes Czernin and David Mankoff
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 1S-2S; DOI: https://doi.org/10.2967/jnumed.115.157818
  • You have access
    Quo Vadis: PET and Single-Photon Molecular Breast Imaging
    Richard L. Wahl
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 3S-8S; DOI: https://doi.org/10.2967/jnumed.115.159202
  • You have access
    Clinical Diagnosis and Management of Breast Cancer
    Elizabeth S. McDonald, Amy S. Clark, Julia Tchou, Paul Zhang and Gary M. Freedman
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 9S-16S; DOI: https://doi.org/10.2967/jnumed.115.157834
  • You have access
    18F-FDG PET/CT for Staging and Restaging of Breast Cancer
    David Groheux, Alexandre Cochet, Olivier Humbert, Jean-Louis Alberini, Elif Hindié and David Mankoff
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 17S-26S; DOI: https://doi.org/10.2967/jnumed.115.157859
  • You have access
    Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment
    Gary J.R. Cook, Gurdip K. Azad and Vicky Goh
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 27S-33S; DOI: https://doi.org/10.2967/jnumed.115.157867
  • You have access
    18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer
    Stefanie Avril, Raymond F. Muzic, Donna Plecha, Bryan J. Traughber, Shaveta Vinayak and Norbert Avril
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 34S-39S; DOI: https://doi.org/10.2967/jnumed.115.157875
  • You have access
    Breast-Dedicated Radionuclide Imaging Systems
    David F.C. Hsu, David L. Freese and Craig S. Levin
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 40S-45S; DOI: https://doi.org/10.2967/jnumed.115.157883
  • You have access
    Nuclear Breast Imaging: Clinical Results and Future Directions
    Wendie A. Berg
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 46S-52S; DOI: https://doi.org/10.2967/jnumed.115.157891
  • You have access
    Molecular Imaging of Biomarkers in Breast Cancer
    Gary A. Ulaner, Chris C. Riedl, Maura N. Dickler, Komal Jhaveri, Neeta Pandit-Taskar and Wolfgang Weber
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 53S-59S; DOI: https://doi.org/10.2967/jnumed.115.157909
  • You have access
    Mouse Models of Breast Cancer: Platforms for Discovering Precision Imaging Diagnostics and Future Cancer Medicine
    H. Charles Manning, Jason R. Buck and Rebecca S. Cook
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 60S-68S; DOI: https://doi.org/10.2967/jnumed.115.157917
  • You have access
    Novel Strategies for Breast Cancer Imaging: New Imaging Agents to Guide Treatment
    Elizabeth S. McDonald, David A. Mankoff and Robert H. Mach
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 69S-74S; DOI: https://doi.org/10.2967/jnumed.115.157925
  • You have access
    Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer
    Amy M. Fowler, Amy S. Clark, John A. Katzenellenbogen, Hannah M. Linden and Farrokh Dehdashti
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 75S-80S; DOI: https://doi.org/10.2967/jnumed.115.157933
  • You have access
    Imaging Diagnostic and Therapeutic Targets: Human Epidermal Growth Factor Receptor 2
    Geraldine Gebhart, Patrick Flamen, Elisabeth G.E. De Vries, Komal Jhaveri and Zena Wimana
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 81S-88S; DOI: https://doi.org/10.2967/jnumed.115.157941
  • You have access
    The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis
    Laura Kenny
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 89S-95S; DOI: https://doi.org/10.2967/jnumed.115.157958
  • You have access
    Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation
    Suzanne C. van Es, Clasina M. Venema, Andor W.J.M. Glaudemans, Marjolijn N. Lub-de Hooge, Sjoerd G. Elias, Ronald Boellaard, Geke A.P. Hospers, Carolina P. Schröder and Elisabeth G.E. de Vries
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 96S-104S; DOI: https://doi.org/10.2967/jnumed.115.157974
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 57 (Supplement 1)
Journal of Nuclear Medicine
Vol. 57, Issue Supplement 1
February 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Clinical and Translational Molecular Imaging of Breast Cancer
  • Most Cited
  • Most Read
Loading
  • Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
  • Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study
  • Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
More...
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire